Obviously, the pyrazolone moiety plays crucial roles in occupying active sites of binding pocket, forming the pi-alkyl with Val 1155 in c-Met and H-bond with Asp 1046 in VEGFR-2 kinase, suggesting the broad prospect of pyrazolones developing as antitumor agents in the future.